ALE1
ALE1 is a pharmaceutical drug with 1 clinical trials. Currently 1 active trials ongoing.
Registry-listed formulations
This catalogue entry has no confirmed scientific concept.
Each study is counted once in the molecule profile. Registry products remain separate. Naming an ingredient does not establish that products are interchangeable or what participants received.
3 source entries across 1 studies. This list may not include all unresolved or historical entries.
- ALE1 IRegistry product
Linked study entry; product equivalence not established
Formulation reported by source: CAPSULE, HARD
View study and source - ALE1 IIIRegistry product
Linked study entry; product equivalence not established
Formulation reported by source: CAPSULE, HARD
View study and source - ALE1Registry product
Linked study entry; product equivalence not established
Formulation reported by source: CAPSULE, HARD
View study and source
Success Metrics
Phase Distribution
Phase Distribution
0
Early Stage
1
Mid Stage
0
Late Stage
Highest Phase Reached
Phase 1/2Trial Status & Enrollment
0.0%
0 of 0 finished
0.0%
0 ended early
1
trials recruiting
1
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Clinical Trials (1)
Drug Details
- Intervention Type
- Drug
- Total Trials
- 1